Member Info for roger65

This is pretty much what I’ve posted several times before: that GDR will sell approx 35k tests to the NHS for the first year at least. There will be more sales abroad.

That’s at least approx £3m in income so hopefully £1.5m in profit. Together with cash in the bank, annual R&D tax credit of about £850k, further Grant money from DEVOTE and increasing sales from AIHL (already at least £250k p.a) this should not only give GDR enough cash for another year but also cover the cost of De Novo route for FDA approval ($500k) which should take about another 7 or 8 months now that they’ve been granted access to that route and assuming they’re just getting on with it straight away.

The stars need to align but success for this company is within reach within the next year. It will all be much clearer in a weeks time. GDR is currently at the mercy of a lot of traders but hopefully this step up might see an end to the endless volatility. Here’s hoping it all works out.

* Cheek

Yes nissan. Trades on LSE look like a sea of blue. Either the algos are just off or we can expect to see some large delayed Sells later this morning.

Would be great if Check could drop some other news on the market just before the 31st. Further roll out of AIHL tests in NHS perhaps?

How the f will it ever get to 30p if you are always trying to put everyone investor out there off actually buying stock?

No, I don’t get it. I really try to see all pov from investors but this one doesn’t make any sense. Good luck slacker but I think you may need to go and talk to someone.

Slacker, we get it! However, if someone has stumbled across GDR a few weeks or months ago when the sp was hovering around the placing price then you’re constant negative diatribe on all things GDR would have actually prevented a newbee from making some money. It might also have contributed to people deciding against investing in GDR and reducing the small recovery we’ve had recently. I say small, that’s as far as lths are concerned. Any potential newbies would have made well over 100% profit by now but if anyone read a single one of your posts and took it seriously then they’d have steered clear. I’ve lost plenty of money here but I’m not now going to recover my losses by painting an overly negative picture and pushing an astonishingly destructive narrative on the stock.

There is still massive potential here. If July 31st gives us news that NICE fully approved GdR’s CYP2C19 test and that the NHS will begin using it then there is easily another 100% + to be made here. I suspect your agenda is anything but altruistic and so fully expect you to still be here knocking the company even when the sp eventually gets back to above 10p. Not necessarily now in July but perhaps by the end of the year? Yes, definitely possible.

I’m referring to the delay from 10th July to 31st!! Jeez

‘ My best guess is share price will fall sharply after NICE update....back to 2p.’

So why are you here Stocksaint? Why? Just admit you’re short and then people can choose to filter you or not.

You’re back in the bin for me. Knew it was a mistake to see what you’d been telling everyone. Gosh you’ve been busy today again…!

Error, delay of just * 3 weeks…

And in which case Billybob the delay of 6 weeks is nothing like enough time for the NHS to implement an increase in lab testing to the point where no GDR tests will be required. They have neither the time nor the money to do that.

GDR tests have been manufactured and sales will start in Sept, maybe Oct now owing to the short delay. Money will start rolling in and that’s just from the UK. There will be many other territories who will take the NICE seal of approval as a Green light to begin using the tests.

Stock imagines they are going to either not approve it or… approve it but tell everyone they’re not going to use any. If that were the case they could have just announced that on 10th July.

Woah that's starting to look mightily impressive.

Good results or any positive news from this point on and this will soar.

Another £425 davey? Really? Does the fact you are the only person on the entire planet buying these shares not tell you you are throwing your money down the drain. I feel someone needs to talk to you, and soon!

Another glaring omission from all of Stocksaint’s recent ‘evidence’ suggesting the NHS ‘might not use any’ of the GDR tests is that in the April document from NICE was this statement - it will "take significant time to ramp up" To full capacity for lab testing. NICE delayed the publication of its final guidance by three weeks. Stocksaint is therefore suggesting that just3 weeks is enough time for NHS and NICE to increase the lab testing capacity by over 100% in order to meet the required 110k tests per annum in the uk. The delay imho is purely down to the NHS working out how to implement the necessary training of staff and getting the kits in place. GDR ramped up production in May - June by over 7000. Oh yeah, because they have the distinct impression the NHS will not be needing any. Enough for one day.

Lionel, don't bother. I've binned him so no idea what he's said but just ask yourself why would someone need to post here umpteen times a day to tell everyone it's going to be a disaster? He's short and absolutely needs this to go south.

If he was a serious investor then he'd just put his money where his mouth is and let us all plough our hard earned cash into this knowing when the day comes he can go short and make a killing. But he doesn't do that does he. For weeks and weeks he's relentlessly trying to sow seeds of doubt. He has an agenda and it's geared firmly toward GDR doing badly. He thinks the NHS might well end up not taking any GDR poc tests at all. None. He thinks the NHS and NICE are taking a few extra weeks to come up with millions of pounds to expedite the creation of nearly double the available lab testing that currently exists in the UK. All the iis that took part in the recent placing will have serious professionals working for them and looking at GDR to see if it's a serious prospect or one that's about to go to the wall, which if this fails it almost certainly will. It has cash left for another 10 months or so if there are no sales of CYP2C19 going forwards.

Starres/stocksaint - if you believe this is what's going to happen then fine, just bugger off and watch the cash fall into your trading account as the sp plummets on the news that NICE and the NHS have decided no GDR tests will be required. You don't need to be responsible for the rest of us and our investments.

Another good day of consolidation here today.

Roll on breaking the 5p barrier by the end of the week. Said it before, I hope with good momentum, sentiment and maybe some other good news dropped just before the 31st this could get as high as 8p. What a day that would be after what lths have been through.

As far as I'm concerned the delay is due to implementation of some kind of roll out for GDR's test. Not, as stocksaint would have had you believe, because they're going to very quickly roll out a plan to inxrease lab testing andthen announce they don't need GDR's test at all. If that was the plan they'd just go ahead and announce they'd decided against it and get on with trying to find the huge amount needed to get lab testing up to full capacity for the whole country. In the current climate they - the NHS - just couldn't do that imho.

For me, full recommendation is nailed on so it's just a question of how many tests will be required and how soon. Remember, as soon as NICE gives a green light there are many other territories that will simply buy up the test immediately.

Can't wait.

I woods not be surprised if there was another short delay. Some have said NICE could announce early but that’s not what I’ve read - earliest by July 31st.

The delay is for implementation, but implementation of what they didn’t say exactly. So Stock and popeye must assume the delay is due to NICE implementing the increase capacity in lab testing because they’re off the opinion GDR’s CYP2 C19 test might not be used at all. Yeah right.

It would actually help enormously if GDR were to release some thoughts on possible sales within the next 6 to 12 months. At least give some clue to the market what they are expecting as a result of NICE Full Recommendation. That would not be breaching any AIM rules. Just a statement of what they are hoping for.

I guess one other thing to consider is...why would the committee from NICE have undergone a second public consultation process if the ultimate aim was to sideline GDR's test altogether and then spend far more on having to build up the lab testing capacity as quickly as possible. Anyway, stock has achieved his aim to sow the seeds of doubt for anyone reading these boards. I hope he IS short come July 31st and that this might put paid to all his efforts to steer people away from what is an excellent test and a company with huge potential to make serious money from it's two gene tests, MT-MRN1 and CYP2C19.

My own view is he's 100% short and working very hard to dissuade as many people as possible from buying shares. Now why would he want to do that?

Stocksaint's view is that NICE will NOT give a FULL recommendation because in his view the NHS will go all out to increase the lab testing, thus making GDR's CYP2C19 tests redundant. They can't give it a FULL recommendation as such because then all NHS Trusts would be obliged to implement use of the tests as soon as possible and within 3 months. Personally i don't think this is the 'brilliant position the company is in' that Cheek was referring to in his summary given at the end of the most recent presentation. I also struggle to think several iis would have happily contributed to the recent placing having all the same facts to base a decision on that we the general public have had access to.

After all GDR has been through, if this happened, I think it would finish the company as the sp would fall through the floor and GDR would have wasted years designing and developing this test. Cheek would have to get AIHL through the FDA De Novo process asap to get sales up and running in order not to run out of money yet again.

Alternatively, there is a view that the NICE guidance will announce the use of GDR's tests asap in order to allow the NHS time to build up testing capacity from the lab testing facilities. I think this is the most likely outcome and that they will designate 35k tests per year according to a specific group type they need to find faster results for.

Dbh I'm still in the red but done really well since lowering my average quite considerably when the sp was below .01p. I'm happy , honestly. Still a long way to go and I'm definitely NOT bashing the company whilst the doc is in charge but...I simply said I wouldn't blame him for taking some profits off the table. I wouldn't blame anyone ever doing that on any share! That's the whole point isn't it?

I just think they will need to put out something a little more concrete before the sp gets going again. Whilst we're relying on tweets/X it wears a tad thin after a while and one has to wonder what's going to happen next. News of a contract would obviously be the ultimate but I think there's more work to be done before we get to that point.

Could be Dr C de-risking? He's done incredibly well on all those huge buys he made when the sp was below .01p after all. No one could blame him for taking some well earned profit off the table.